NIH Administrative Supplements

The CFAR Program at the National Institutes of Health (NIH) invites applications from currently funded CFARs that are eligible for administrative supplements in the following projects/areas of scientific interest:

  1. Basic Research on HIV Infection and Persistence
  2. Infant Immunity for HIV Vaccine Development
  3. Studies to Delineate Sex Differences in the Incidence of Heart, Lung, Blood, and Sleep Comorbidities in People Living with HIV
  4. Formative Research on Behavioral Aspects of Novel Biomedical HIV Prevention and Treatment Regimens
  5. The Evolving Opioid Epidemic and its HIV Consequences
  6. Implementation of Evidence-Based HIV Interventions and Treatments for Health Disparity Populations

Supplement awards are for up to one year with maximum funding per application of up to $150,000 Direct Costs, not including third party indirect costs.

The Johns Hopkins CFAR may submit a maximum of four supplement applications. There are six scientific areas of interest in total.


The purpose of this administrative supplement opportunity is to support innovative research from basic science through implementation research that address key gaps in HIV/AIDS and will advance the field.  This opportunity should build research capacity and be consistent with the recent NIH HIV/AIDS research priorities (NOT-OD-15-137).


Project leaders are restricted to early stage investigators (please see NIH definition of new and early stage investigator) and to established investigators in non-HIV fields who have never received an NIH research award for HIV/AIDS studies. Post-doctoral fellows are eligible to apply if they will assume a faculty position by the time the supplement project and funding begins.

Studies that are a continuation of previously funded CFAR supplements or funded NIH applications that do not address new specific aims are not eligible for funding under this announcement. Additionally, a proposed supplement application that is linked to a proposed application not yet funded is not eligible for funding under this announcement.

  • The CFAR may not fund studies involving new drugs, treatments, or devices, or off-label use of a licensed drug (this includes healthy volunteer studies where drugs are administered).
  • The CFAR may not fund clinical research studies that include randomization to one or more intervention to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.
  • Studies involving human subjects may be subject to additional NIH review prior to initiating the study, which may cause delays. Similarly, for studies with any foreign component, additional NIH review and approval is required prior to the initiation of any study procedures. More information can be found here.


Instructions for Application

The CFAR is allowed to submit four applications in total, so letters of intent will be screened to select the ones that seem most likely to be funded.

Letter of Intent (1 page) must be submitted to by Friday, March 23, 2018 at 9:00 AM. Letters should include the title of the study and a 200 word abstract of the proposed research. Please include how this study would lead to future funding.

Selections for formal application will be notified by Tuesday, March 27, 2018. The due date for formal applications will be announced then.

Please see the Supplement Announcement for full details on the award descriptions and application instructions.

The CFAR Grant Development and Implementation Toolkit is a great resource that is designed to assist in the completion of HIV related grant submissions and to support the implementation of awarded grants. Click here to access the toolkit.

Any questions about the awards or the application process can be directed to